ANI Pharmaceuticals Inc [ANIP] stock prices are up 2.07% to $64.66 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ANIP shares have gain 2.99% over the last week, with a monthly amount glided 7.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ANI Pharmaceuticals Inc [NASDAQ: ANIP] stock has seen the most recent analyst activity on March 14, 2025, when Jefferies initiated its Buy rating and assigned the stock a price target of $80. Previously, JP Morgan started tracking the stock with Overweight rating on March 12, 2025, and set its price target to $85. On December 11, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $80 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $68 on October 11, 2024. CapitalOne initiated its recommendation with a Overweight and recommended $80 as its price target on March 15, 2024. H.C. Wainwright reiterated a Buy rating for this stock on August 22, 2023, and upped its price target to $73. In a note dated March 01, 2023, Guggenheim initiated an Buy rating and provided a target price of $55 on this stock.
The stock price of ANI Pharmaceuticals Inc [ANIP] has been fluctuating between $52.50 and $77.00 over the past year. Currently, Wall Street analysts expect the stock to reach $86 within the next 12 months. ANI Pharmaceuticals Inc [NASDAQ: ANIP] shares were valued at $64.66 at the most recent close of the market. An investor can expect a potential return of 33.0% based on the average ANIP price forecast.
Analyzing the ANIP fundamentals
The ANI Pharmaceuticals Inc [NASDAQ:ANIP] reported sales of 674.07M for trailing twelve months, representing a surge of 43.43%. Gross Profit Margin for this corporation currently stands at 0.57% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.05 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.76.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 63.10 points at the first support level, and at 61.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 65.92, and for the 2nd resistance point, it is at 67.19.
Ratios To Look Out For
It’s worth pointing out that ANI Pharmaceuticals Inc [NASDAQ:ANIP]’s Current Ratio is 2.66. On the other hand, the Quick Ratio is 1.98, and the Cash Ratio is 0.74. Considering the valuation of this stock, the price to sales ratio is 2.08, the price to book ratio is 3.35.
Transactions by insiders
Recent insider trading involved Cook Meredith, SR. VP, GENERAL COUNSEL & SEC., that happened on Jun 13 ’25 when 400.0 shares were sold. SVP, GENERICS, Gutwerg Ori completed a deal on May 15 ’25 to sell 881.0 shares. Meanwhile, HEAD OF RARE DISEASE Mutz Christopher sold 4000.0 shares on May 14 ’25.
